68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Prostate Cancer|Brain Tumor|PET/CT Imaging
Interventions: DRUG: 68Ga-RM26-RGD|DRUG: 18F-FDG|DRUG: 68Ga-RM26|DRUG: 68Ga-RGD
Sponsor: Peking Union Medical College Hospital